One company, Teleflex Inc., is figuring out how to run super-lean in the present cost-concious healthcare environment. Another, Stryker, is on an acquisition spree, while Edwards Lifesciences appears to have truly hit pay dirt when it comes to its TAVR technology.
There are strikingly different stories among the medical device companies with the best stock performance during the first three months of 2016. (Download Qmed’s full spreadsheet of the 91 stocks, and read about the worst-performing companies.)
